Tagging SNP association study of the IL-1β gene (IL1B) and childhood-onset mood disorders

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 150, Issue 5, 2009, Pages 653-659

  Misener, Virginia L ^a   Gomez, Lissette ^a   Wigg, Karen G ^a   King, Nicole ^b   Kiss, Eniko ^c   Daróczi, Gabriella ^c   Kapornai, Krisztina ^c   Tamás, Zsuzsanna ^d   Mayer, László ^c,h   Gádoros, Júlia ^d   Baji, Ildikó ^d,i   Kennedy, James L ^b   Kovacs, Maria ^e   Vetró, Ágnes ^c   Barr, Cathy L ^a,f,g   Benák, István ^h   Osváth, Viola Kothencné ^h   Dombovári, Edit ^h   Kaczvinszky, Emília ^h   Besnyo, Márta ^d   Székely, Judit ⁱ   more..

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF SZEGED   (Hungary)

^d Vadaskert Hospital   (Hungary)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g TORONTO WESTERN HOSPITAL   (Canada)

^h UNIVERSITY OF SZEGED   (Hungary)

ⁱ SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Childhood; Genetics; Il 1 depression; Inflammatory cytokine

Indexed keywords

INTERLEUKIN 1BETA;

ARTICLE; CHILD; CHILDHOOD; DEPRESSION; FAMILY STUDY; GENE; GENETIC LINKAGE; GENETIC RISK; HUMAN; IL1B GENE; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; AGE OF ONSET; CHILD; CHROMOSOME MAPPING; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-1BETA; LINKAGE DISEQUILIBRIUM; MALE; MOOD DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE; SIBLINGS;

EID: 67649421210     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30885     Document Type: Article

References (69)

1. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. 2002. Merlin-Rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 30(1):97-101.
2. Altar CA. 1999. Neurotrophins and depression. Trends Pharmacol Sci 20(2):59-61.
3. Antonijevic IA. 2006. Depressive disorders-Is it time to endorse different pathophysiologies? Psychoneuroendocrinology 31(1):1-15.
4. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263-265.
5. Barrientos RM, Sprunger DB, Campeau S, Higgins EA, Watkins LR, Rudy JW, Maier SF. 2003. Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist. Neuroscience 121(4):847-853.
6. Brambilla F, Monteleone P, Maj M. 2004. Interleukin-1beta and tumor necrosis factor-alpha in children with major depressive disorder or dysthymia. J Affect Disord 78(3):273-277.
7. Chakravorty M, Ghosh A, Choudhury A, Santra A, Hembrum J, Roychoudhury S. 2006. Interaction between IL1B gene promoter polymorphisms in determining susceptibility to Helicobacter pylori associated duodenal ulcer. Hum Mutat 27(5):411-419.
8. Charlton BG. 2000. The malaise theory of depression: Major depressive disorder is sickness behavior and antidepressants are analgesic. Med Hypotheses 54(1):126-130.
9. Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, Rogus J, Beck JD, Offenbacher S, Cork MJ., et al. 2006. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 15(4):519-529.
10. Clayton D. 1999. A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 65(4):1170-1177.
11. Dantzer R. 2001. Cytokine-induced sickness behavior: Where do we stand? Brain Behav Immun 15(1):7-24.
12. Dantzer R. 2004. Cytokine-induced sickness behaviour: A neuroimmune response to activation of innate immunity. Eur J Pharmacol 500(1-3): 399-411.
13. Dantzer R. 2006. Cytokine, sickness behavior, and depression. Neurol Clin 24(3):441-460.
14. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. 2005. Efficiency and power in genetic association studies. Nat Genet 37(11): 1217-1223.
15. de Craen AJ, Posthuma D, Remarque EJ, van den Biggelaar AH, Westendorp RG, Boomsma DI. 2005. Heritability estimates of innate immunity: An extended twin study. Genes Immun 6(2):167-170.
16. Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25(2):115-121.
17. Dunn AJ, Swiergiel AH, de Beaurepaire R. 2005. Cytokines as mediators of depression: What can we learn from animal studies? Neurosci Biobehav Rev 29(4-5):891-909.
18. Durany N, Michel T, Zochling R, Boissl KW, Cruz-Sanchez FF, Riederer P, Thome J. 2001. Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr Res 52(1-2):79-86.
19. El-Omar EM,CarringtonM,Chow WH,McColl KE, Bream JH,YoungHA, Herrera J, Lissowska J, Yuan CC, Rothman N., et al. 2000. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404(6776):398-402.
20. El-Omar EM,Carrington M,Chow WH,McColl KE, Bream JH,Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N., et al. 2001. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 412(6842):99.
21. Ewens WJ, Spielman RS. 2001. The transmission/disequilibrium test. In: Balding DJ, editor. Handbook of statistical genetics. Chichester, West Sussex, England; Hoboken, NJ: John Wiley & Sons, Ltd. pp 507-518.
22. Farmer A, Elkin A, McGuffin P. 2007. The genetics of bipolar affective disorder. Curr Opin Psychiatry 20(1):8-12.
23. Feng Y, Vetró A, Kiss E, Kapornai K, Daroczi G, Mayer L, Tamás Z, Baji I, Gadoros J, King N., et al. 2008. Association of the neurotrophic tyrosine kinase receptor 3 (NTRK3) gene and childhood-onset mood disorders. Am J Psychiatry 165(5):610-616.
24. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invidia L, Celani L, Scurti M., et al. 2007. Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128(1):92-105.
25. Geller B, Zimerman B, Williams M, Bolhofner K, Craney JL. 2001. Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder. Am J Psychiatry 158(1):125-127.
26. Gershenfeld HK, Philibert RA, Boehm GW. 2005. Looking forward in geriatric anxiety and depression: Implications of basic science for the future. Am J Geriatr Psychiatry 13(12):1027-1040.
27. Gordon D, Finch SJ. 2005. Factors affecting statistical power in the detection of genetic association. J Clin Invest 115(6):1408-1418.
28. Goshen I, Kreisel T, Ben-Menachem-Zidon O, Licht T, Weidenfeld J, Ben-Hur T, Yirmiya R. 2008. Brain interleukin-1 mediates chronic stressinduced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry 13(7):717-728.
29. Halbreich U. 2006. Major depression is not a diagnosis, it is a departure point to differential diagnosis-clinical and hormonal considerations (a commentary and elaboration on Antonejevic's paper). Psychoneuroen-docrinology 31(1):16-22, author reply 23-24.
30. Hayley S, Poulter MO, Merali Z, Anisman H. 2005. The pathogenesis of clinical depression: Stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience 135(3):659-678.
31. Johnson RW. 2002. The concept of sickness behavior: Abrief chronological account of four key discoveries. Vet Immunol Immunopathol 87(3-4): 443-450.
32. Johnson VJ, Yucesoy B, Luster MI. 2004. Genotyping of single nucleotide polymorphisms in cytokine genes using real-time PCR allelic discrimination technology. Cytokine 27(6):135-141.
33. Kapornai K, Gentzler AL, Tepper P, Kiss E, Mayer L, Tamas Z, Kovacs M, Vetro A. 2007. Early developmental characteristics and features of major depressive disorder among child psychiatric patients in Hungary. J Affect Disord 100(1-3):91-101.
34. Kaufman J, Martin A, King RA, Charney D. 2001. Are child-, adolescent-, and adult-onset depression one and the same disorder? Biol Psychiatry 49(12):980-1001.
35. Kendler KS, Gardner CO, Lichtenstein P. 2008.Adevelopmental twin study of symptoms of anxiety and depression: Evidence for genetic innovation and attenuation. Psychol Med Jun 26: 1-9.
36. Kimura R, Nishioka T, Soemantri A, Ishida T. 2004. Cis-acting effect of the IL1B C-31T polymorphism on IL-1 beta mRNA expression. Genes Immun 5(7):572-575.
37. Kiss E, Gentzler AM, George C, Kapornai K, Tamas Z, Kovacs M, Vetro A. 2007. Factors influencing mother-child reports of depressive symptoms and agreement among clinically referred depressed youngsters in Hungary. J Affect Disord 100(1-3):143-151.
38. Laird NM, Horvath S, Xu X. 2000. Implementing a unified approach to family-based tests of association. Genet Epidemiol 19(Suppl 1): S36-S42.
39. Lee KA, Ki CS, Kim HJ, Sohn KM, Kim JW, Kang WK, Rhee JC, Song SY, Sohn TS. 2004. Novel interleukin 1beta polymorphism increased the risk of gastric cancer in a Korean population. J Gastroenterol 39(5):429-433.
40. Lind H, Haugen A, Zienolddiny S. 2007. Differential binding of proteins to the IL1B -31 T/C polymorphism in lung epithelial cells. Cytokine 38:43-48.
41. Liu X, Gentzler AL, Tepper P, Kiss E, Kothencne VO, Tamas Z, Vetro A, Kovacs M. 2006. Clinical features of depressed children and adolescents with various forms of suicidality. J Clin Psychiatry 67(9):1442-1450.
42. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A. 2003. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 60(5):497-502.
43. Mellios N, Huang HS, Grigorenko A, Rogaev E, Akbarian S. 2008. A set of differentially expressed miRNAs, including miR-30a-5p, act as posttranscriptional inhibitors of BDNF in prefrontal cortex.HumMol Genet 17(19):3030-3042.
44. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215.
45. Misener VL, Gomez L, Wigg KG, Luca P, King N, Kiss E, Daroczi G, Kapornai K, Tamas Z, Mayer L., et al. 2008 Cytokine genes, TNF, IL1A, IL1B, IL6, IL1RN and IL10, and childhood-onset mood disorders. Neuropsychobiology 58(2):71-80.
46. Myint AM, Kim YK. 2003. Cytokine-serotonin interaction through IDO: A neurodegeneration hypothesis of depression. Med Hypotheses 61(5-6):519-525.
47. Ober C, Hoffjan S. 2006. Asthma genetics 2006: The long and winding road to gene discovery. Genes Immun 7(2):95-100.
48. Papiol S, Rosa A, Gutierrez B, Martin B, Salgado P, Catalan R, Arias B, Fananas L. 2004. Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder. J Med Genet 41(3):219-223.
49. Purcell S, Cherny SS, Sham PC. 2003. Genetic power calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19(1):149-150.
50. Raison CL, Capuron L, Miller AH. 2006. Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol 27(1): 24-31.
51. Schiepers OJ, Wichers MC, Maes M. 2005. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29(2):201-217.
52. Schlatter J, Ortuno F, Cervera-Enguix S. 2004. Monocytic parameters in patients with dysthymia versus major depression. J Affect Disord 78(3):243-247.
53. Schmidt HD, Duman RS. 2007. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 18(5-6):391-418.
54. Sherrill JT, Kovacs M. 2000. Interview schedule for children and adolescents (ISCA). J Am Acad Child Adolesc Psychiatry 39(1):67-75.
55. Silk JS, Shaw DS, Skuban EM, Oland AA, Kovacs M. 2006. Emotion regulation strategies in offspring of childhood-onset depressed mothers. J Child Psychol Psychiatry 47(1):69-78.
56. Smith RS. 1991. The macrophage theory of depression. Med Hypotheses 35(4):298-306.
57. Soiampornkul R, Tong L, Thangnipon W, Balazs R, Cotman CW. 2008. Interleukin-1beta interferes with signal transduction induced by neurotrophin-3 in cortical neurons. Brain Res 1188:189-197.
58. Strauss J, Barr CL, George CJ, Devlin B, Vetro A, Kiss E, Baji I, King N, Shaikh S, Lanktree M., et al. 2005. Brain-derived neurotrophic factor variants are associated with childhood-onset mood disorder: Confirmation in a Hungarian sample. Mol Psychiatry 10(9):861-867.
59. Strober M, Lampert C, Schmidt S, Morrell W. 1993. The course of major depressive disorder in adolescents: I. Recovery and risk of manic switching in a follow-up of psychotic and nonpsychotic subtypes. J Am Acad Child Adolesc Psychiatry 32(1):34-42.
60. The International HapMap Consortium. 2003. The International HapMap Project. Nature 426(6968):789-796.
61. Tong L, Balazs R, Soiampornkul R, Thangnipon W, Cotman CW. 2008. Interleukin-1beta impairs brain derived neurotrophic factor-induced signal transduction. Neurobiol Aging 29(9):1380-1393.
62. van den Biggelaar AH, Gussekloo J, de Craen AJ, Frolich M, Stek ML, van der Mast RC, Westendorp RG. 2007. Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Exp Gerontol 42(7):693-701.
63. Viljoen M, Panzer A. 2005. Non-termination of sickness behavior as precipitating factor for mental disorders. Med Hypotheses 65(2):316-329.
64. Wamboldt MZ, Schmitz S, Mrazek D. 1998. Genetic association between atopy and behavioral symptoms in middle childhood. J Child Psychol Psychiatry 39(7):1007-1016.
65. Wamboldt MZ, Schmitz S, Mrazek D. 2000. Genetic association between atopy and behavioral symptoms in middle childhood (corrigendum). J Child Psychol Psychiatry 41(5):674.
66. Webster MJ, Herman MM, Kleinman JE, Shannon Weickert C. 2006. BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan. Gene Expr Patterns 6(8): 941-951.
67. Winokur G. 1997. All roads lead to depression: Clinically homogeneous, etiologically heterogeneous. J Affect Disord 45(1-2):97-108.
68. Yu YW, Chen TJ, Hong CJ, Chen HM, Tsai SJ. 2003. Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response. Neuropsychopharmacology 28(6):1182-1185.
69. Zhu CB, Blakely RD, Hewlett WA. 2006. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 31(10):2121-2131.